Prothena Corp Public Ltd Co
PRTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001559053
In the last 90 days, Prothena Corp Public Ltd Co insiders filed 4 open-market purchases and 2 sales; 187 institutions reported holding it in 13F filings for Q2 2026, worth $462.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Prothena Corp Public Ltd Co as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 169
- −16 vs. Q4 2023
- Shares held
- 53.5M
- −26.4K (0.0%) vs. Q4 2023
- Total value
- $1.33B
- −$619.7M (−31.9%) vs. Q4 2023
- New holders
- 25
- 58 more added
- Sold out
- 41
- 61 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 187 | $462.7M |
| Q1 2026 | 186 | $459.5M |
| Q4 2025 | 182 | $451.6M |
| Q3 2025 | 187 | $415.8M |
| Q2 2025 | 189 | $253.6M |
| Q1 2025 | 161 | $647.2M |
| Q4 2024 | 171 | $741.3M |
| Q3 2024 | 164 | $855.8M |
| Q2 2024 | 160 | $1.05B |
| Q1 2024 | 169 | $1.33B |
| Q4 2023 | 187 | $1.95B |
| Q3 2023 | 187 | $2.56B |
| Q2 2023 | 196 | $3.54B |
| Q1 2023 | 192 | $2.51B |
| Q4 2022 | 201 | $2.98B |
| Q3 2022 | 183 | $2.69B |
| Q2 2022 | 167 | $1.21B |
| Q1 2022 | 174 | $1.61B |
| Q4 2021 | 196 | $2.12B |
| Q3 2021 | 192 | $2.92B |
| Q2 2021 | 156 | $2.08B |
| Q1 2021 | 146 | $1.00B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Prothena Corp Public Ltd Co; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −5,985−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −5,904−100.0% | Sold out |
| Vident Advisory, LLC | 0 | $0 | 0.00% | −5,639−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −4,256−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,208−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Neo Ivy Capital Management | – | – | – | – | Not filed |